Main Determinants of Severe Neutropenia in Patients with Solid Tumors Receiving Adjuvant Chemotherapy
Journal Title: Iranian Journal of Blood and Cancer - Year 2012, Vol 5, Issue 1
Abstract
Background:Chemotherapy-induced neutropenia as a major toxicity of systemic chemotherapy is commonly associated with substantial mortality and morbidity, and thus identifying its determinants is necessary. This study was undertaken to identify main risk factors of severe neutropenia following adjuvant chemotherapy treatment in a community-based population of patients with cancer in Semnan, Iran. Materials and methods: This prospective study included 828 consecutive patients with histologically proven primary or metastatic solid tumors who received chemotherapy. Demographics data, disease characteristics, and co-morbidities (including current smoking and diabetes) were collected by face to face interviews with the patients and also by referring to their laboratory data and files. Patients underwent complete blood count a week after the first chemotherapy course. Results: Based on the nadir value of the absolute neutrophil count (ANC), 30 patients (3.6%) had severe neutropenia. Multivariable logistic regression analysis showed that advanced age (OR = 5.262, p = 0.012), and the presence of diabetes mellitus (OR = 8.126, p = 0.015) were the main determinants for the appearance of severe neutropenia with the presence of demographics and studied co-morbidities as confounders. Conclusion: We identified advanced age and the presence of diabetes as the main determinants of high-grade neutropenia in solid tumor patients receiving adjuvant chemotherapy in our study population. Keywords: Neutropenia, solid tumor, chemotherapy.
Authors and Affiliations
F. Ghahramanfard, Mohammad Faranoush, R Ghorbani, M. Rahbar
Keywords
Related Articles
- EP ID EP366202
- DOI -
- Views 90
- Downloads 0
Hodgkin’s Lymphoma Occurring Secondary to Autologous Stem Cell Transplantation in Plasma Cell Leukemia; A Case Report
Survival of patients with multiple myeloma has improved substantially because of availability of new therapies including autotransplants, immunomodulating drugs and proteasome-inhibitors. Second primary cancers have emer...
Hyperimmunes Plasma Procurement and Products
This article has no abstract.
Epidemiological features of Central Nervous System tumors at MAHAK Pediatric Cancer Treatment and Research Center
Background: In this study, we examined the epidemiologic characteristics of childhood brain tumors in patients referred to MAHAK Pediatric Cancer Treatment and Research Center (one of the main national referral centers...
Hypoxia Preconditioning Promotes Survival And Clonogenic Capacity Of Human Umbilical Cord Blood Mesenchymal Stem Cells
Background: In recent decade, human umbilical cord blood derived mesenchymal stem cells (hUCB-MSCs) provide enormous potential for appropriate cell therapy, but they have limited growth potential and cease to proliferate...
Application of Nanoscaffolds and Mesenchymal Stem Cells in Tissue Engineering
Stem cell research has obtained much prominence in recent years for its therapeutic potential in dealing with serious diseases, many of which are essentially incurable by routine therapies. Mesenchymal stem cells with pl...